dr. geyer discusses challenges in her2-positive metastatic breast cancer management
Published 5 years ago • 762 plays • Length 2:05Download video MP4
Download video MP3
Similar videos
-
1:31
dr. geyer on the rationale for the katherine trial in her2-positive breast cancer
-
1:29
dr. geyer on impact of targeted agents in her2 breast cancer
-
6:08
first-line treatment of her2-positive metastatic breast cancer
-
1:52
dr. geyer discusses pertuzumab in her2 breast cancer
-
8:40
first-line treatment of her2-positive metastatic breast cancer
-
57:03
ask the expert: early-stage hormone receptor-positive, her2-positive & triple-positive breast cancer
-
4:11
what is her2 positive breast cancer? | treatment/therapies for her2 positive breast cancer
-
20:11
her2-positive breast cancer—reduce your risk of recurrence | access health
-
8:49
case study: treating her2-positive metastatic breast cancer, part i
-
19:38
medical update: her2-positive metastatic breast cancer
-
1:11
dr. janni on challenges facing the treatment of her2-positive breast cancer
-
54:02
navigating shifts in the treatment landscape for metastatic her2-positive breast cancer
-
52:22
living long term with mbc: making treatment decisions
-
1:01
dr. hamilton discusses challenges with approved treatments for her2-positive breast cancer
-
0:35
key challenge associated with the management of hr /her2- breast cancer
-
0:57
dr. kass on optimal treatment sequencing in her2-positive breast cancer
-
0:57
dr. marks on the role of tkis in her2-positive breast cancer
-
8:12
her2 testing in metastatic breast cancer
-
1:06
dr. brufsky on challenges in breast cancer
-
1:22
dr. pegram on challenges facing the treatment of her2-positive breast cancer
-
1:12
dr. pegram on challenges in neoadjuvant treatment for her2-positive breast cancer
-
7:44
hormonal and her2-targeted therapy in early breast cancer